This Euroscicon meeting which took place on the 24th – 26th March 2015, explored new research into tuberculosis detection, treatments and vaccination, as well as new developments in controlling and preventing tuberculosis infection. Euroscicon are pleased to announce that a meeting report from this event has been published on Amazon.
Dr Sanjib Bhakta, Birkbeck College, London, United Kingdom
Professor P K Das, Academic Medical Centre, University of Amsterdam, The Netherlands
Dr Michael Head, Research Associate, University College London, UK
Dr Sandrine Lesellier, PhD, MRCVS BAC4, Animal and Plant Health Agency (APHA), New Haw, UK
Author: Ms Caroline Pule
Division of Human Genetics and Molecular Biology, Stellenbosch University, Cape Town, South Africa
Editors: Dr Astrid Englezou and Dr Shara Cohen
Buy from [amazon text=Amazon&asin=B017W445E8]
“Dangerous” M. tuberculosis genotypes, their transmission and acquisition of drug resistance- implications for treatment and infection control
Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates
Design, synthesis and studies of new potent and selective anti-tuberculosis agents based on imidazopyrine cores
The immunopathogenesis of tuberculosis in Asian Elephants
Role of TNF-α, IFN-γ, IL- 12p70, IL-4 & IL-1β as early treatment response biomarkers for the detection of MDR-TB
Does HIV modify the association between hyperglycaemia and active tuberculosis
A RAPID SCREENING ASSAY TO DETERMINE THE ANTI-MYCOBACTERIAL PROPERTIES OF METAL/METAL OXIDE NANOPARTICLES.
RIFAMPICIN-LOADED POLY (AMIDO AMINE) NANOGELS.
TARGETED DELIVERY OF ANTITUBERCULAR DRUGS TO THE BRAIN FOR THE TREATMENT OF TUBERCULOUS MENINGITIS.
THE ROLE OF EFFLUX PUMP INHIBITORS ON FIRST- AND SECOND-LINE ANTI-TUBERCULOSIS DRUGS IN RIFAMPICIN MONO-RESISTANT CLINICAL ISOLATES OF MYCOBACTERIUM TUBERCULOSIS.
Format: Kindle Edition
File Size: 2025 KB
Print Length: 29 pages
Simultaneous Device Usage: Unlimited
Publisher: HONNAO (11 Nov. 2015)
Sold by: Amazon Media EU S.à r.l.